Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
VRPX

VRPX - Virpax Pharmaceuticals, Inc. Stock Price, Fair Value and News

$0.010.00 (0.00%)
Market Closed

Price Targets

VRPX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VRPX Price Action

Last 90 days

-50%

Trailing 12 Months

-99.9%

VRPX RSI Chart

VRPX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VRPX Valuation

Market Cap

10.6K

Price/Earnings (Trailing)

-9e-4

EV/EBITDA

0.09

Price/Free Cashflow

-6e-4

MarketCap/EBT

-6e-4

VRPX Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

VRPX Fundamentals

VRPX Earnings

VRPX Profitability

Free Cashflow Yield

-157.3K%

VRPX Investor Care

About Virpax Pharmaceuticals, Inc.

VRPX
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
 CEO
 WEBSITEvirpaxpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES7

Virpax Pharmaceuticals, Inc. Frequently Asked Questions

VRPX is the stock ticker symbol of Virpax Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Virpax Pharmaceuticals, Inc. is 10.63 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VRPX's fair value in chart for subscribers.

The fair value guage provides a quick view whether VRPX is over valued or under valued. Whether Virpax Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Virpax Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VRPX.